News Articles

Patient recruitment starts for the international PRO-SID study evaluating Panzyga® for primary... LACHEN, Switzerland -Friday 18 September 2020  

(BUSINESS WIRE)-- Octapharma is pleased to announce that the first site for the international PRO-SID (Primary Infection Prophylaxis with Panzyga® in Secondary Immunodeficiency in Chronic Lymphocytic Leukaemia) study was initiated in Milan, Italy, and patient recruitment is underway. Additional...

Smiths Detection Completes Acquisition of PathSensors -Tuesday 4 August 2020  

(BUSINESS WIRE) -- Smiths Detection, a global leader in detection and screening technologies, today confirmed that it has completed the acquisition of PathSensors, a leading bio-technology solutions and environmental-testing company, based in Baltimore, MD, USA. The acquisition strengthens...

Pitney Bowes Appoints Sheila A. Stamps to its Board of Directors -Wednesday 15 July 2020  

(BUSINESS WIRE)-- Pitney Bowes (NYSE: PBI), a global technology company that provides commerce solutions in the areas of shipping, mailing, data and ecommerce, today announced the election of Sheila A. Stamps to its board of directors, effective September 1, 2020. “We are pleased to welcome...

Smiths Detection enters into agreement to acquire PathSensors to expand its biological-detection capability -Friday 3 July 2020

(BUSINESS WIRE)-- Smiths Detection, a global leader in detection and screening technologies, today announces that it has entered into an agreement to acquire PathSensors, a leading bio-technology solutions and environmental-testing company based in Baltimore, MD. The acquisition expands Smiths...

Smiths Detection to Supply Security-Screening Equipment to Kuwait International Airport -Wednesday 1 July 2020  

(BUSINESS WIRE) -- Smiths Detection, a leading threat-detection and security-technology company, will supply hold-baggage screening equipment for Kuwait’s new International Airport Terminal 2, which is currently under construction. The contract includes the installation of HI-SCAN 10080 XCT...

Smiths Medical Announces Ventilator Training Alliance App Partnership -Thursday 28 May 2020  

(BUSINESS WIRE)-- Smiths Medical announced today it has joined several of the world’s other ventilator manufacturers in the Ventilator Training Alliance (VTA) to support frontline medical providers access to a centralized repository of ventilator training. The content can be found in a mobile...

Smiths Medical Acquires the Business of Access Scientific, LLC, Expanding Vascular Access Offering -Thursday 14 May 2020  

(BUSINESS WIRE)-- Smiths Medical, a leading global medical device manufacturer, announces today the acquisition of the business of Access Scientific, LLC, a privately-held company based in San Diego, CA. Access Scientific is a broad-spectrum vascular access and infection prevention company that...

Octapharma demonstrates commitment to improving haemophilia A treatment at the 13th Annual Congress of the European... -Friday 7 February 2020

(BUSINESS WIRE)-- Octapharma had a prominent role as a Sponsor of the 13th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) Congress this week, which takes place in The Hague, The Netherlands, from February 5–7, 2020. Octapharma’s activities at the...

Final results from the NuProtect study demonstrating efficacy of Nuwiq® (simoctocog alfa) in previously untreated... -Thursday 12 December 2019

(BUSINESS WIRE) -- Octapharma has announced today that the final results from the NuProtect study, the largest prospective study of a single factor VIII (FVIII) product in true PUPs with severe haemophilia A, were presented today in an oral presentation at the American Society of Hematology...

VF Corporation Announces New Science-Based Targets to Accelerate Social and Environmental Responsibility Programs -Sunday 8 December 2019  

(BUSINESS WIRE) -- VF Corporation (NYSE: VFC), one of the world’s largest apparel, footwear and accessories companies, today published the latest iteration of its Made for Change Sustainability & Responsibility report, including the announcement of industry-leading science-based targets...

PCI Security Standards Council Publishes New Standard for Contactless Payments -Saturday 7 December 2019

(BUSINESS WIRE) -- Today the PCI Security Standards Council (PCI SSC) published a new data security standard for solutions that enable merchants to accept contactless payments using a commercial off-the-shelf (COTS) mobile device (e.g., smartphone or tablet) with near-field communication (NFC)....

Edoardo Rizzi, Former Viavi and TekComms Leader, Joins Empirix Leadership Team -Tuesday 5 November 2019  

(BUSINESS WIRE)-- Empirix® Inc., a leader in network test automation and service and application performance visibility today announced that Edoardo Rizzi has been appointed SVP, Product Management and Marketing. Prior to his appointment, Rizzi held leadership roles at Viavi/JDSU, Trendium, and...

Update of Summary of Product Characteristics for Nuwiq® includes data on effective bleed protection with... -Monday 30 September 2019

(BUSINESS WIRE) -- Octapharma announced today that the European Medicines Agency has authorised an updated Summary of Product Characteristics (SmPC) for Nuwiq® that includes information on personalised prophylaxis in patients with haemophilia A. The updated SmPC can be accessed at...

Quake Global Launches Global LTE as the Latest Innovation for Our Best-Selling Products, QPRO™ and Q4000™ -Tuesday 17 September 2019  

(BUSINESS WIRE)-- Quake Global, Inc. is excited to announce the availability of global LTE in our best-selling products, QPRO™ and Q4000™, which both come with bi-directional and dual-mode communication protocols over global satellite and cellular networks. Q4000 and QPRO are now...

Octapharma Present New Data on the Benefits Of Nuwiq® In Patients With Haemophilia A at the International... -Monday 8 July 2019

(BUSINESS WIRE) -- Octapharma announced today that new data on the benefits of Nuwiq® in patients with haemophilia A were presented during a scientific symposium at the 27th International Society on Thrombosis and Haemostasis (ISTH) Congress in Melbourne, Australia. The symposium, entitled...

Octapharma communicates an update on the development of SubQ-8, a novel subcutaneous recombinant FVIII, at ISTH 2019 -Sunday 7 July 2019

(BUSINESS WIRE) -- Octapharma announced that an update on the clinical development plan and pre-clinical data with SubQ-8 were presented today in a scientific symposium at the 27th International Society on Thrombosis and Haemostasis (ISTH) Congress in Melbourne, Australia. SubQ-8 combines...

Octapharma to Present New Data on Management of People with Haemophilia A or von Willebrand Disease at ISTH 2019 -Wednesday 3 July 2019

(BUSINESS WIRE) -- New scientific data on Octapharma’s Haematology portfolio will be presented at the upcoming 27th Congress of the International Society on Thrombosis and Haemostasis (ISTH), taking place in Melbourne, Australia, from 6 to 10 July 2019. Five abstracts have been accepted for...

DVCOM and DrayTek Conclude Their 7th Edition of DrayTek Channel Champs -Sunday 16 June 2019  

One of the most exciting annual events in the networking space, DrayTek Channel Champs recently concluded its 7th edition. Organized by prominent Taiwan-based networking solutions provider, DrayTek in association with their master distributors in GCC, DVCOM Technology, the competition commenced...

WIN 2019 Symposium: WINnovation and Global Deployment of Precision Oncology -Saturday 18 May 2019

(BUSINESS WIRE)-- The 11th WIN Symposium in Precision Oncology will be held in Paris, France on June 23-24, 2019. ASCO® endorsed for the past 11 years, the WIN symposium will deliver an exciting line-up of speakers in Paris (France) on June 23-24, 2019 to discuss Innovation and Global...

Comprehensive Tumor Profiling Promises New Therapeutic Options for Patients with Advanced Cancer -Monday 22 April 2019

(BUSINESS WIRE)-- Published in Nature Medicine* today, results of WINTHER, the first study pioneered by the WIN Consortium** - - Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial - shows that RNA profiling together with DNA testing matches more...